|
ANKRD26 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.791400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.594600E-01 |
| Normal-vs-Stage2 |
4.115000E-01 |
| Normal-vs-Stage3 |
1.772950E-01 |
| Normal-vs-Stage4 |
2.615600E-01 |
| Stage1-vs-Stage2 |
4.864000E-01 |
| Stage1-vs-Stage3 |
7.123700E-02 |
| Stage1-vs-Stage4 |
1.517800E-01 |
| Stage2-vs-Stage3 |
1.141020E-01 |
| Stage2-vs-Stage4 |
1.425550E-01 |
| Stage3-vs-Stage4 |
8.667600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.689600E-01 |
| Normal-vs-AfricanAmerican |
7.399800E-01 |
| Normal-vs-Asian |
6.136600E-01 |
| Caucasian-vs-AfricanAmerican |
8.767000E-01 |
| Caucasian-vs-Asian |
6.655400E-01 |
| AfricanAmerican-vs-Asian |
6.059200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.081200E-01 |
| Normal-vs-Female |
3.025000E-01 |
| Male-vs-Female |
1.987850E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.132200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.289800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.741200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.015800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.461800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.393200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.650800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.761190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.289200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.730000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.404300E-02 |
| Normal-vs-Grade 2 |
2.674200E-01 |
| Normal-vs-Grade 3 |
1.495950E-01 |
| Normal-vs-Grade 4 |
1.196290E-02 |
| Grade 1-vs-Grade 2 |
8.704400E-03 |
| Grade 1-vs-Grade 3 |
5.584200E-03 |
| Grade 1-vs-Grade 4 |
2.421700E-03 |
| Grade 2-vs-Grade 3 |
3.141400E-03 |
| Grade 2-vs-Grade 4 |
2.622600E-04 |
| Grade 3-vs-Grade 4 |
1.648010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.616200E-02 |
| Normal-vs-ccB subtype |
1.745240E-01 |
| ccA subtype-vs-ccB subtype |
1.424730E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.389000E-01 |
| Normal-vs-N1 |
4.574400E-01 |
| N0-vs-N1 |
5.123000E-01 |
|
|
